Agenda & Speakers

Agenda

8:30 a.m.

Registration and Light Breakfast
AJC Forum 1101 (all morning sessions)

9:00 a.m.

Welcome: William Bentley, Robert E. Fischell Distinguished Chair & Inaugural Director of the
Robert E. Fischell Institute for Biomedical Devices, Fischell Department of Bioengineering, University of Maryland; Stefanie Trop, Director, Office of Life Sciences, Department of Commerce

9:15 a.m.

Engineering the Future: Trends in MedTech
Moderator: Bob Storey, Managing Partner & Founder, LaunchPort, LLC
Panelists: William Bentley; Youseph Yazdi, Faculty and Director, Johns Hopkins Center for Bioengineering Innovation & Design (CBID); Henry Brem, Professor and Director of Neurosurgery, Johns Hopkins University; Kyp Sirinakis, Co-founder and Managing Partner, Epidarex Capital; George Davis, SVP Strategic Advisory/Wexford SciTech Venture Fund Manager, Evergreen Advisors & Wexford SciTech Venture Fund

10:00 a.m.

Health Equity in Focus: Driving Social Change Through MedTech
Moderator: Troy LeMaile-Stovall, CEO, TEDCO
Panelists: Kolaleh Eskandanian, Vice President and Chief Innovation Officer, Children's National Hospital; Kristen Valdes, CEO, b.well Connected Health; Katrina Holland, Executive Director, MedTech Color

10:45 a.m.

Break

11:05 a.m.

Seizing Opportunities: National and Regional MedTech Initiatives
Moderator: John Sawyer, Executive Director, Mid-Atlantic Quantum Alliance; Director, Strategic Research Initiatives, University of Maryland
Panelists:, Michael Wolfson, Program Director, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health (NIH); Amy Jenkins, Mission Office Director, Advanced Research Projects Agency for Health (ARPA-H); Douglas Kelly, Deputy Director for Science, Center for Devices and Radiological Health, Food and Drug Administration (FDA); Mike Pieck, Director, Catalyze Program, National Heart, Lung, and Blood Institute, NIH; Scott Shepard, Senior Policy Advisor, NIST

11:50 a.m.

Collaboration Catalyst Quick Pitch

12:10 p.m.

Community Collaboration Lunch: Learning and Networking

1:10 p.m.

Regulatory Science in Action: Developing Emerging Technologies Alongside the FDA
Moderator: Valerie Merkle, Sr. Director, Medical & Scientific Affairs, Terumo Aortic
Panelists: Ed Margerrison, Director Office of Science and Engineering at FDA, Bill Vogt, Assistant Director, Division of Biomedical Physics, FDA; Frank Samuelson, Research Physicist, Office of Science and Engineering Laboratories, FDA

1:50 p.m.

Break

2:00 p.m.

Parallel Panel Session 1

Track A: Navigating Maryland's MedTech Startup Ecosystem: Here's What Really Works
AJC Forum 1101
Moderator: Dean Chang, Chief Innovation Officer and Associate Vice President for Innovation & Entrepreneurship and Economic Development, University of Maryland
Panelists: Ric Hughen, CEO, Linshom Medical; Howard Carolon, Co-Founder and CEO, CoapTech; Ian White, Associate Chair and Director of Undergraduate Studies, Fischell Department of Bioengineering, University of Maryland; Xiaonao Liu, Founder and CEO, NanoBioFAB

Track B: Building Resilient MedTech Manufacturing: Opportunities for Onshoring and Strengthening Supply Chain
Kim Building 1105
Moderator: Mike Kelleher, Executive Director, Maryland Manufacturing Extension Partnership (MEP)
Panelists: Ken Malone, Founder and Executive Officer, Early Charm Ventures, LLC; Bob Storey, Managing Partner, The LaunchPort™; Chad Schneider, CEO and Founder, Root3 Labs; Cyrus Etemad-Moghadam, President & Founder, Rapid Prototyping and Manufacturing Technologies, LLC (RPM Tech)

Track C: Preparing for Tomorrow: Workforce Training Resources for Maryland's MedTech Industry
Kim Building 1107
Moderator: Anne Balduzzi, Managing Director, Entrepreneur and Ecosystem Empowerment (E3), TEDCO
Panelists: Jen Spencer Heilman, Program Director, for MTIP/MIIC, University of Maryland Baltimore County; Chris Frew, Founder, BioBuzz; Greg MIller, HealthTech Alley; Drew Greenblatt, President & Owner, Marlin Steel Wire Products LLC

2:50 p.m.

Break

3:05 p.m.

Parallel Panel Session 2

Track A: Payment and Partnership Pathways: Navigating Reimbursement and Revenue Models
AJC Forum 1101
Moderator: Christina DeMur, Director of Technology Development, Johns Hopkins Technology Ventures (JHTV)
Panelists: Ibraheem Badejo, Senior R&D Director, External Front End Innovation, Johnson & Johnson; Brad Rabinovitz, COO, Longeviti Neuro Solutions; Amber Fee, Manager Data Analytics, MITRE HFPP-TTP; Sebastian Seiguer, CEO and co-founder, Scene Health

Track B: Joining Forces: A Call to Action to Mobilize Local Stakeholders to Secure CHIPS Support for Microelectronics
Kim Building 1105
Moderator: Pamela Abshire, Professor, Department of Electrical and Computer Engineering, University of Maryand
Panelists: Brian Jamieson, Founder & CTO, Diagnostic Biochips; Scott Shepard, Senior Policy Advisor, NIST; Brian Darmody, Chief Strategy Officer, Association of University Research Parks

Track C: Attracting Investment: Taking Advantage of Maryland's Biotechnology Investment Incentive Tax Credit (BIITC)
Kim Building 1107
Moderator: Matt Cimino, Manager Business & Innovation Development, Maryland Department of Commerce
Panelists: Deborah Hemingway, Ecphora Capital; Samantha Scott, Founder and CEO, JuneBrain; Abigail McKnight, Program Manager, Tax Incentives, Maryland Department of Commerce

3:55 p.m.

Break

4:00 p.m.

Closing Remarks, AJC Forum 1101

4:15 - 6:00 p.m.

Happy Hour and Networking, AJC Forum 1101

Speaker Bios

Pamela Abshire

Professor, Department of Electrical and Computer Engineering, University of Maryand

Ibraheem Badejo

Senior R&D Director, External Front End Innovation, Johnson & Johnson

Kory Bailey

CEO, UpSurge Baltimore

Anne Balduzzi, B.S.

Managing Director, Entrepreneur & Ecosystem Empowerment, TEDCO

William Bentley, Ph.D.

Professor and Director
University of Maryland

Henry Brem, MD

Professor and Director of Neurosurgery, Johns Hopkins University SOM

Harvey Cushing Professor,
Professor of Neurosurgery, Ophthalmology, Oncology and Biomedical Engineering,
Director, Department of Neurosurgery, Director, Hunterian Neurosurgical Research Laboratory, Johns Hopkins University School of Medicine

Henry Brem has developed new tools and techniques that have changed the field of neurosurgery. Brem carried out the pivotal clinical study that introduced navigational imaging into the neurosurgical suite. His work led to the FDA's approval of the first image guidance computer system for intraoperative localization of tumors. Furthermore, he has changed the surgical armamentarium against brain tumors by inventing and developing Gliadel® wafers to intraoperatively deliver chemotherapy to brain tumors. His work with Bob Langer, has shown that surgeons can accurately deliver potent therapies directly at the tumor site.

Brem has changed the surgical treatment of brain tumors by introducing new approaches for targeted therapy. He developed new classes of polymers and microchips for drug delivery that are custom synthesized for the agent being developed. The polyanhydrides, which were the first new treatments for brain tumors that the FDA had approved in 23 years, have been shown in his laboratory to be biocompatible and potent. He then designed and led the clinical trials demonstrating safety and efficacy. He has published over 400 research papers, 58 book chapters, 11 patents, and an H index of 100 with over 42,000 citations. In addition to his academic work he has worked closely with biotech companies to develop new technologies.
The worldwide impact of the Hopkins Neurosurgery Department is reflected in 20 Neurosurgery Department Chairmen that have come from the Department between 2000 and 2023.

Brem's teaching was recognized by the Hopkins Professors Award for Excellence in Teaching in 1996. In 1998 he was elected to the Institute of Medicine of the National Academy of Sciences. In 2000 he was awarded the Grass Award by the Society of Neurological Surgeons for meritorious research; in 2001 he received the Founders Award of the Controlled Release Society; in 2004 he received the New York University Distinguished Alumni Award; in 2005 he was co-recipient of the Society for Biomaterials Technology Innovation and Development Award and was named the Coleman Fellow in Life Sciences at Ben-Gurion University. In 2011 he delivered the commencement address for the Johns Hopkins University School of Medicine. He has been recognized by the Castle Connolly Guide each year from 2002 in “America’s Top Doctors”, and from 2005 – present in “America’s Top Doctors for Cancer”. In 2013, the Society for NeuroOncology and the Section on Tumors of the AANS/CNS named him as the recipient of the Abhijit Guha Award. In 2014, The Johns Hopkins University established the Henry Brem Endowed Chair in Neurosurgery. In 2015 Brem was selected to receive the Castle Connolly National Physician of the Year Award for Clinical Excellence. The award is given annually to five physicians whose dedication, talents, and skills have improved the lives of thousands of people throughout the world. In 2017, Brem was awarded the Albert Nelson Marquis Lifetime Achievement Award and the Johns Hopkins University Provost’s Award for Excellence in Faculty Mentoring. Brem was awarded the Andy Parsa Mentorship Award by the American Association of Neurological Surgeons and the Congress of Neurological Surgeons in 2018, and in 2019 was inducted into the Baltimore Jewish Hall of Fame by JCC of Greater Baltimore and awarded the Society of Neurological Surgeons Medical Student Teaching Award in 2021. Brem received the Johns Hopkins Sixth Annual Dean’s Distinguished Mentoring Award. Henry Brem has been selected as the “Honored Guest” for the 2024 Annual Meeting of the Congress of Neurological Surgeons in Houston.

Brem’s devotion to patient care, clinical excellence and translational science has brought together a unique group of neurosurgeons and investigators that have changed the field of neurosurgery. He continues his practice of complex brain surgery and to lead the Johns Hopkins Neurosurgery Department.

Howard Carolan, MPH/MBA

Chief Executive Officer, CoapTech

Dean Chang, Ph.D., MBA

University of Maryland Chief Innovation Officer

Matthew Cimino

Manager Business & Innovation Development, Maryland Department of Commerce

Marjie Cota, BS

Director Entrepreneurial Services, bwtech@UMBC

Brian Darmody

Chief Strategy Officer, Association of University Research Parks

George Davis, BS

SVP Strategic Advisory, Evergreen Advisors; Manager, Wexford SciTech Venture Fund

Christina De Mur

Director Technology Development, Johns Hopkins Tech Ventures

Kolaleh Eskandanian

Vice President and Chief Innovation Officer, Children’s National Hospital

Cyrus Etemad-Moghadam, M.Sc.

President & Founder, RPM Tech

Steve Falk

Chief Technologist, GE HealthCare

Amber Fee

Manager Data Analytics, MITRE HFPP-TTP

Chris Frew

Founder, BioBuzz Networks and CEO, Workforce Genetics

Drew Greenblatt

President & Owner, Marlin Steel Wire Products LLC

Jen Spencer Heilman

Program Director, Maryland Technology Internship Program (MTIP) at UMBC

Deborah Heminigway, Ph.D.

Managing Partner, Ecphora Capital

Katrina Holland

Executive Director, MedTech Color

Richard Hughen, B.S., MBA

CEO, Linshom Medical

Brian Jamieson, Ph.D.

Founder and CTO, Diagnostic Biochips, Inc.

Amy Jenkins, Ph.D.

Director of Health Science Futures Mission Office, ARPA-H

Mike Kelleher

CEO/Executive Director, Maryland MEP

Douglas Kelly, MD

Deputy Center Director for Science, Food and Drug Administration

Troy LeMaile-Stovall

CEO, TEDCO

As the CEO of TEDCO—Maryland’s $200M+ AUM, 60M+ operating budget, $2.7B impact, 1.4 TVPI, economic engine for technology companies—Troy A. LeMaile-Stovall leads the organization’s mission to support economic empowerment through the cultivation of a diverse and inclusive entrepreneurial innovation ecosystem. He also serves as a Strategic Advisor for Hunter Lewis, LLC, an investment management advisory firm, led by Cambridge Associates' Co-Founder Hunter Lewis.

An accomplished & award-winning CEO with significant experience in leading and implementing strategic plans via strong coaching and a focus on metrics, Troy has led or co-led over $3B in debt and equity offerings.

Troy has significant Board level experience leading Audit & Compensation Committees and has served on a number of for-profit and non-profit boards including the University of Maryland School of Medicine’s Board of Visitors, Parkway Properties (NYSE:PKY, Compensation Committee Chair, Audit and Corporate Governance Committees), Archipelago Learning (NASDAQ:ARCL, Audit and Compensation Committee), Internet America (NASDAQ:GEEK, Audit Chair and Compensation Committee), School Status, EpiCor Software (Chair, Audit Committee), National Society of Black Engineers (NSBE), Southern Methodist University (SMU) School of Engineering, SMU Dept. of Electrical Engineering (Chair), UDC Foundation (Treasurer), MD Cybersecurity Council, MD Clean Energy Center Advisory Council, MD Technology Council, DC Chamber of Commerce (Workforce Committee Chair), MemberSuite (Chair, Audit Committee), DC Housing Enterprises, National Association of College and University Business Officers (NACUBO) Advisory Group on Leadership Diversity, and his church Landover, MD-based Zion Church, led by Sr. Pastor Keith Battle, where he serves as Treasurer. During his time on Boards, Troy has had an impact on efforts in the areas of strategic and operational planning, mergers, fiscal planning, capital formation, diversity and inclusion, organizational design, and marketing. He is a NACD Certified Board Director (NACD.DC).

Troy is an entrepreneur at heart; he founded the management consulting firm LeMaile-Stovall, LLC and co-founded GulfSouth Capital, the family investment/venture capital office for US Ambassador to Portugal and SkyTel founder John N. Palmer, where he served as the first President and CEO.

His previous positions include serving as the Chief Operating Officer (COO) at the University of the District of Columbia, Interim President of Zenith Education Group; Principal at Butler Snow Advisory Services; Executive Vice President and COO of Howard University; and Senior Vice President and Chief Financial Officer (CFO) at Jackson State University, where he was awarded the Thurgood Marshall HBCU CFO of the Year. Earlier in his career, Troy held positions at McKinsey & Company, Southwestern Bell Telephone, AT&T Bell Labs (youngest recipient of the Key Award), and Rockwell International.

Troy is a subject matter expert in capital stack formation and a frequent speaker on venture capital, economic development, and higher education administration, among other topics. He has published articles on entrepreneurship, venture capital, economic development, diversity and inclusion, culture, and higher education.

Troy graduated cum laude from Southern Methodist University with a bachelor of science in electrical engineering, earned a master of science in computer science from Stanford University as a Bell Labs One Year on Campus Fellow, and received an MBA from Harvard University (1st Year Honors).

He was included in the Leadership Greater Washington Signature Program Class of 2019, selected to the Baltimore Business Journal’s 2020 Leadership Trust, and the DC Chamber of Commerce selected him for the “2020 Chamber Choice Chairman’s Award.”

In 2021, he was named to the Agenda’s “Board Diversity 100 Board-Ready Candidates You’ve Never Heard Of” list and in 2022, he was awarded “Most Admired CEO” by The Daily Record, and named a “Tech Titan” by the Washingtonian. He is a NACD Certified Director, was selected for the 2023 class for the NACD Accelerate Audit Committee Pipeline program, is a 2023 Inductee into the Baltimore Dealmakers Hall of Fame and is a 2023 Baltimore Business Journal “Power 10” awardee. His top 5 CliftonStrengthsTM are Belief, Connectedness, Strategic, Achiever, and Learner and he has a “i” DiSC® style.

Troy has also coached an award-winning youth robotics team and is a USA Swimming-certified stroke-and-turn and chief judge official. A triathlete himself, he is married to marathoner Sonya L. Wiggins and is the father of two academically gifted and multi-talented young athletes, Zora Lauren, and Langston Anthony as well as their AkiPoo dog (Akita and Poodle mix), Hamilton.

Xiaonao Liu, Ph.D.

CEO, Nanobiofab

Ed Margerrison

Director Office of Science and Engineering, FDA

Ken Malone

Executive Officer,
Early Charm

Abigail McKnight

Program Manager, Tax Incentives, Maryland Department of Commerce

Valerie Merkle Ph.D.

Sr. Director, Medical & Scientific Affairs, Terumo Aortic

Matthew Miessau

Principal, Epidarex Capital

Greg Miller, MBA

Executive Director, Health Tech Alley

Mike Pieck

Director, Catalyze Program, National Heart, Lung, and Blood Institute, NIH

Brad Rabinovitz, B.S.

COO, Longeviti Neuro Solutions

John Sawyer

Executive Director, Mid-Atlantic Quantum Alliance; Director, Strategic Research Initiatives, University of Maryland

Chad Schneider, PE

CEO, Root3 Labs

Samantha Scott, MS, Ph.D.

Founder & CEO, JuneBrain Inc.

Sebastian Seiguer, JD, MBA

Chief Executive Officer and Co-Founder, Scene Health

Scott Shepard

Senior Policy Advisor, NIST

Kyp Sirinakis

Co-founder and Managing Partner, Epidarex Capital

Bob Storey

Managing Partner & Founder, LaunchPort, LLC

Stefanie Trop

Director, Life Sciences, Maryland Department of Commerce

Kristen Valdes

CEO, b.well Connected Health

Bill Vogt

Assistant Director, Division of Biomedical Physics, FDA; Frank Samuelson, Research Physicist, Office of Science and Engineering Laboratories, FDA

Martha Wang

Assistant Director, Fischell Institute for Biomedical Devices

Ian White, Ph.D.

Professor, University of Maryland, Fischell Department of Bioengineering

Michael Wolfson, Ph.D.

Program Director, NIH/NIBIB

Youseph Yazdi, Ph.D., MBA

Johns Hopkins Center for Bioengineering Innovation & Design (CBID), Center Director, Faculty

Lorem Ipsum

Massa ultricies mi quis hendrerit dolor magna eget est. Tristique sollicitudin nibh.

Lunch Tables

Meet Troy LeMaile-Stovall, CEO of TEDCO

FDA Meetings: When and How to Meet with the FDA

Ahmad Bayat, Amarex

Reimbursement for Your New Device

Amber Fee, NIH

Customer Discovery in Healthcare Innovation

Stephen Kinsey and Marck-Arthur Clerveau, MedStar Health

Diversifying MedTech

Katrina Holland, MedTech Color

Automating Innovation and Compliance in Medical Devices

Juliana Buonanno, TechSlice, LLC

Fundraising in a Challenging Market

Matthew Misseau, Epidarex Capital, and Ric Hughen, Linshom Medical

Maryland Industrial Partnerships (MIPS) Funding for Product Development

Joe Naft and Ronnie Gist, University of Maryland

Legal Challenges Facing Emerging Technologies

Sean Burke, Duane Morris, LLP

Introduction to the FDA

Ed Margerrison, FDA

Agenda & Speakers

Agenda

Speaker Bios

Pamela Abshire

Ibraheem Badejo

Kory Bailey

Anne Balduzzi, B.S.

William Bentley, Ph.D.

Henry Brem, MD

Howard Carolan, MPH/MBA

Dean Chang, Ph.D., MBA

Matthew Cimino

Marjie Cota, BS

Brian Darmody

George Davis, BS

Christina De Mur

Kolaleh Eskandanian

Cyrus Etemad-Moghadam, M.Sc.

Steve Falk

Amber Fee

Chris Frew

Drew Greenblatt

Jen Spencer Heilman

Deborah Heminigway, Ph.D.

Katrina Holland

Richard Hughen, B.S., MBA

Brian Jamieson, Ph.D.

Amy Jenkins, Ph.D.

Mike Kelleher

Douglas Kelly, MD

Troy LeMaile-Stovall

Xiaonao Liu, Ph.D.

Ed Margerrison

Ken Malone

Abigail McKnight

Valerie Merkle Ph.D.

Matthew Miessau

Greg Miller, MBA

Mike Pieck

Brad Rabinovitz, B.S.

John Sawyer

Chad Schneider, PE

Samantha Scott, MS, Ph.D.

Sebastian Seiguer, JD, MBA

Scott Shepard

Kyp Sirinakis

Bob Storey

Stefanie Trop

Kristen Valdes

Bill Vogt

Martha Wang

Ian White, Ph.D.

Michael Wolfson, Ph.D.

Youseph Yazdi, Ph.D., MBA

Lorem Ipsum

Sponsors

Lunch Tables

Meet Troy LeMaile-Stovall, CEO of TEDCO

FDA Meetings: When and How to Meet with the FDA

Reimbursement for Your New Device

Customer Discovery in Healthcare Innovation

Diversifying MedTech

Automating Innovation and Compliance in Medical Devices

Fundraising in a Challenging Market

Maryland Industrial Partnerships (MIPS) Funding for Product Development

Legal Challenges Facing Emerging Technologies

Introduction to the FDA